ClinicalTrials.Veeva

Menu

Post-stroke Pathway: Analysis and Link With One Year Sequelae in a French Cohort of Stroke Patients (PAPASéPA)

U

University Hospital of Bordeaux

Status

Unknown

Conditions

Stroke
Stroke Sequelae

Treatments

Other: Telephone Interview

Study type

Observational

Funder types

Other

Identifiers

NCT03865173
CHUBX 2016/30

Details and patient eligibility

About

The link between post-stroke pathways and patient sequelae have not yet been clearly defined. The main purpose is to identify the post-stroke life pathways components associated with sequalae at 3 months and 1 year after the acute stroke episode.

Full description

Stroke is a serious health event, involving the entire health care system and generating considerable socioeconomic weight for society. Knowledge of the components, the diversity and the scalability of post-stroke life pathways is currently not sufficient. Moreover the link between post-stroke pathways and patient sequelae have not yet been clearly defined.

The main purpose is to identify the post-stroke life pathways components associated with sequalae at 3 months and 1 year after the acute stroke episode. The secondary objectives are: 1) To define a typology of the life pathways of stroke patients, , 2) To analyze the social and geographical inequalities in the management of stroke, 4) To estimate the cost of the pathway elements of stroke management; 5) Measure the sequelae of stroke patients at three months and one year after the acute episode.

The design is a prospective multicenter cohort study with a follow up to 1 year after the acute episode, managed in several hospitals in the Aquitaine region (France).

Enrollment

1,138 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient being over 18 years of age living in metropolitan France;
  • Patient with recent stroke (not before 2019) whose diagnosis confirmed by a neuro-vascular physician;
  • Patient managed for stroke in one of the 13 participating hospitals of the Aquitaine region;
  • Patient giving consent to participate to PAPASéPA;
  • Patient to be alive at the end of the acute management hospital stay

Exclusion criteria

  • Patient refuse to participate to PAPASéPA
  • Patient died during the initial stay

Trial contacts and locations

13

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems